Results 21 to 30 of about 861,750 (227)
JACC: Cardiovascular Interventions, 2022 OBJECTIVES The aim of this study was to report the midterm outcomes at 1 year in the expanded first-in-human experience with the transfemoral EVOQUE system (Edwards Lifesciences) for tricuspid regurgitation (TR).
J. Webb +29 more
semanticscholar +1 more source
Hepatology Communications, EarlyView., 2022 Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo +19 more
wiley +1 more source
Transcatheter Tricuspid Valve Replacement: Illustrative Case Reports and Review of State-of-Art
Journal of Clinical Medicine, 2023 Tricuspid regurgitation (TR) is one of the most common heart valve diseases, associated a with poor prognosis since significant TR is associated with an increased mortality risk compared to no TR or mild regurgitation.
M. Barreiro-Pérez +10 more
semanticscholar +1 more source
Frontiers in Cardiovascular Medicine, 2023 The tricuspid valve is a complex structure with normal function dependent on the leaflet morphology, right atrial and annular dynamics, and right ventricular and chordal support.
D. Blusztein, R. Hahn
semanticscholar +1 more source
EuroIntervention, 2022 BACKGROUND Transcatheter tricuspid valve replacement (TTVR) is rapidly emerging as a therapeutic option amongst patients with secondary tricuspid regurgitation.
A. Scotti +15 more
semanticscholar +1 more source
Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]
, 2012 Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias +6 more
core +1 more source
Post-stenotic aortic dilatation. [PDF]
, 2006 Aortic stenosis is the most common valvular heart disease affecting up to 4% of the elderly population. It can be associated with dilatation of the ascending aorta and subsequent dissection.
Jahangiri Marjan +5 more
core +2 more sources
JACC: Cardiovascular Interventions, 2021 OBJECTIVES The purpose of this observational first-in-human experience was to investigate the feasibility and safety of the EVOQUE tricuspid valve replacement system and its impact on short-term clinical outcomes.
N. Fam +24 more
semanticscholar +1 more source
Transcatheter versus surgical aortic-valve replacement in high-risk patients. [PDF]
, 2011 BACKGROUND: The use of transcatheter aortic-valve replacement has been shown to reduce mortality among high-risk patients with aortic stenosis who are not candidates for surgical replacement.
Makkar, Raj R +47 more
core +1 more source
4-Year Follow-Up after Transatrial Transcatheter Tricuspid Valve Replacement with the LuX-Valve
Journal of Cardiovascular Development and Disease, 2022 Tricuspid regurgitation (TR) has become one of the most common valve diseases. Patients with severe TR are often at high surgical mortality risk. Transcatheter tricuspid valve interventions have emerged as a promising alternative to open-heart surgery ...
Xiaoping Ning +8 more
doaj +1 more source